Pharmaceutical Technology on MSN
Simcere and Stanford partner to develop IPF therapies
If the research is successful, Simcere may in-license the molecule and obtain all global rights to the product.
The e-Lung score is associated with mortality and a decline in FVC when applied to CT scans at baseline in patients with non-IPF ILD.
Not intended for UK and US audiences Nerandomilast long-term survival modeling presented at American Thoracic Society (ATS) 2026 and European ...
AI models suggest IPF is a dysregulation of aging, not just accelerated aging, with unique gene expression patterns. Key pathways in IPF and aging include TGF-β signaling, oxidative stress, ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
Multiphoton microscopy can help quantify collagen signatures, thereby mapping the fibrotic microenvironment in idiopathic pulmonary fibrosis.
Idiopathic pulmonary fibrosis (IPF) is a disease that causes scarring in the lungs. Eventually, the lungs can become so scarred that they can’t pull enough oxygen into the bloodstream. IPF is a ...
Familial pulmonary fibrosis represented 13% of fibrotic ILD overall, with higher proportions in IPF (18%) and unclassifiable ILD (15%) than in SARD-ILD (9%). Across diagnostic subgroups, familial ...
Flow Space on MSN
Laura Dern on Diane Ladd's pulmonary fibrosis battle
The Oscar winner is honoring her mother's legacy by teaching women to fight for better care from their doctors.
What is idiopathic pulmonary fibrosis (IPF)? Idiopathic pulmonary fibrosis (IPF) is a debilitating and fatal lung disease that affects approximately 3 million people worldwide. Despite the condition ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results